Showing 14,281 - 14,300 results of 29,668 for search '(( 50 ((we decrease) OR (a decrease)) ) OR ( 5 ((step decrease) OR (nn decrease)) ))', query time: 1.06s Refine Results
  1. 14281

    DataSheet_1_Precancerous Cervical Lesion Among Adult Women With Human Immune Deficiency Virus on Anti Retroviral Therapy At Saint Peter Specialized Hospital, Ethiopia: A Hospital-B... by Wondimu Zelalem (13152318)

    Published 2022
    “…Statistical significance was considered at a P-valve less than 0.05.</p>Result<p>A total of 267 women who were on ART were included in the study and the prevalence of precancerous cervical lesion was 7.5% with 95% CI =4.10%-10.50%. …”
  2. 14282

    Data: Median heart rate per minute of motionless dolphins at surface from Towards non-invasive heart rate monitoring in free-ranging cetaceans: a unipolar suction cup tag measured... by Kagari Aoki (9994507)

    Published 2021
    “…Heart rate monitoring in free-ranging cetaceans to understand their behavioural ecology and diving physiology is challenging. Here, we developed a simple, non-invasive method to monitor the heart rate of cetaceans in the field using an electrocardiogram-measuring device and a single suction cup equipped with an electrode. …”
  3. 14283
  4. 14284

    Table_1_Campylobacter Colonization, Environmental Enteric Dysfunction, Stunting, and Associated Risk Factors Among Young Children in Rural Ethiopia: A Cross-Sectional Study From th... by Dehao Chen (4966207)

    Published 2021
    “…<p>Livestock farming provides a possible mechanism by which smallholder farmers can meet their household need for animal source foods (ASF), which may reduce the risk of stunting. …”
  5. 14285

    Different Phenotypes of the Two Chinese Probands with the Same c.889G>A (p.C162Y) Mutation in <i>COCH</i> Gene Verify Different Mechanisms Underlying Autosomal Dominant Nonsyndromi... by Qi Wang (22418)

    Published 2017
    “…The results presented bilateral sensorineural hearing loss with a decreasing pattern, involving the low frequencies. …”
  6. 14286
  7. 14287

    Data_Sheet_1_Comparison of Postnatal Growth Charts of Singleton Preterm and Term Infants Using World Health Organization Standards at 40–160 Weeks Postmenstrual Age: A Chinese Sing... by Li Zhang (8200)

    Published 2021
    “…The Z-scores for length/height, weight, and BMI of preterm infants relative to the WHO standards gradually decreased from 1.20, 1.13, and 0.74 at 40–44 weeks PMA to 0.67, 0.42, and 0.03 at 132–160 weeks PMA, respectively; Z-scores for HC of preterm infants rapidly decreased from 0.73 to 0.29 at 40–50 weeks PMA, and then fluctuated in the range of 0.08–0.23 at 50–160 weeks PMA. …”
  8. 14288

    Table_1_Neurophysiological and Neuroradiological Changes in Children With Chronic Kidney Disease.XLSX by Sameh A. Abd El Naby (9645500)

    Published 2020
    “…</p><p>Methods: The study included 50 patients with CKD admitted to a pediatric nephrology unit. …”
  9. 14289

    Table_1_HLA-A*11:01:01:01, HLA-C*12:02:02:01-HLA-B*52:01:02:02, Age and Sex Are Associated With Severity of Japanese COVID-19 With Respiratory Failure.xlsx by Seik-Soon Khor (7244753)

    Published 2021
    “…After multivariate analysis controlling for other confounding factors and comorbidities, HLA-A*11:01:01:01 [P = 3.34E-03, OR = 3.41 (1.50–7.73)], age at diagnosis [P = 1.29E-02, OR = 1.04 (1.01–1.07)] and sex at birth [P = 8.88E-03, OR = 2.92 (1.31–6.54)] remained significant. …”
  10. 14290
  11. 14291

    Transfection efficiency corrected <sup>3</sup>H-gemcitabine uptake in HEK293 (A), AsPC-1 (B), and MIA PaCa-2 (C) cells with or without transfection of hCNT3 cDNA. by Robert J. Paproski (282968)

    Published 2013
    “…Uptake values were corrected for transfection efficiency as described in the <a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0056423#s2" target="_blank">methods</a> section. …”
  12. 14292
  13. 14293

    DataSheet1_Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatmen... by Ziqiang Li (247218)

    Published 2022
    “…</p><p>Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%–50%) in humans and rats, while CIP hardly changed circulating GA and PCA. …”
  14. 14294

    DataSheet2_Pharmacokinetic herb-drug interactions: Altered systemic exposure and tissue distribution of ciprofloxacin, a substrate of multiple transporters, after combined treatmen... by Ziqiang Li (247218)

    Published 2022
    “…</p><p>Results: Concurrent use of PCE substantially reduced circulating CIP (approximately 40%–50%) in humans and rats, while CIP hardly changed circulating GA and PCA. …”
  15. 14295

    Light-intensity dependence of net oxygen production and consumption, as measured with a membrane-inlet mass spectrometer (MIMS), of wild type <i>Synechocystis</i>, its ΔOx and ΔFlv... by R. Milou Schuurmans (798363)

    Published 2015
    “…Experiments with <i>Synechocystis</i> and its mutant derivatives were conducted at 18°C and <i>Chlorella</i> at 30°C. ●, oxygen evolution measured as an increase in the concentration of <sup>32</sup>O<sub>2</sub>; ◊, oxygen uptake measured as a decrease in the concentration of <sup>36</sup>O<sub>2</sub>; Δ, net rate of photosynthesis (i.e. rate of net oxygen evolution + rate of oxygen uptake). …”
  16. 14296

    Trends in faunal bone remains in four coastal middens (A–D) and size changes for <i>Scarus</i> spp. (parrotfish) and <i>Cellana</i> spp. (intertidal limpets) (E) recovered from arc... by John N. Kittinger (203130)

    Published 2011
    “…<p>Midden remains show decreases in marine fish and increases in domesticated mammals (pigs [<i>Sus scrofa]</i> and dogs [<i>Canis familiaris</i>]) through time, suggesting a change in basic subsistence patterns in Hawaiian prehistory with a decreased reliance on fish versus domesticates. …”
  17. 14297

    Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…Background<p>We compared the lowering effects of pemafibrate and omega-3 fatty acid ethyl on fasting apolipoprotein (apo) B-48 (apoB-48), a marker that reflects postprandial hypertriglyceridemia, which is one of the residual risks for atherosclerotic cardiovascular disease (ASCVD) with statin treatment.…”
  18. 14298

    Table_2_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…Background<p>We compared the lowering effects of pemafibrate and omega-3 fatty acid ethyl on fasting apolipoprotein (apo) B-48 (apoB-48), a marker that reflects postprandial hypertriglyceridemia, which is one of the residual risks for atherosclerotic cardiovascular disease (ASCVD) with statin treatment.…”
  19. 14299

    Table_1_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…Background<p>We compared the lowering effects of pemafibrate and omega-3 fatty acid ethyl on fasting apolipoprotein (apo) B-48 (apoB-48), a marker that reflects postprandial hypertriglyceridemia, which is one of the residual risks for atherosclerotic cardiovascular disease (ASCVD) with statin treatment.…”
  20. 14300

    Table_1_The effects of pemafibrate and omega-3 fatty acid ethyl on apoB-48 in dyslipidemic patients treated with statin: A prospective, multicenter, open-label, randomized, paralle... by Yasutaka Takeda (3165264)

    Published 2023
    “…Background<p>We compared the lowering effects of pemafibrate and omega-3 fatty acid ethyl on fasting apolipoprotein (apo) B-48 (apoB-48), a marker that reflects postprandial hypertriglyceridemia, which is one of the residual risks for atherosclerotic cardiovascular disease (ASCVD) with statin treatment.…”